pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
Endpoints·3h ago·1 min read
save

Redesign Health merges with ARC Global in $2B deal to help hospitals build startups

Health tech venture firm Redesign Health is merging with ARC Global, the innovation arm of Sheba Medical Center, to help hospitals in different countries develop and sell software. The new company will combine the two ...

Oct 22, 2026·read at Endpoints ↗DealNeutral

(L-R) Sheba Medical Center director general Yitshak Kreiss, Redesign Health chairman Stephen Klasko, ARC Global founder and president Eyal Zimlichman and Redesign Health CEO Brett Shaheen October 22, 2026 08:00 AM EDT Health Tech Re­design Health merges with ARC Glob­al in $2B deal to help hos­pi­tals build star­tups Ngai Yeung Health Tech Reporter Health tech ven­ture firm Re­design Health is merg­ing with ARC Glob­al, the in­no­va­tion arm of She­ba Med­ical Cen­ter, to help hos­pi­tals in dif­fer­ent coun­tries de­vel­op … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox. SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER

source

Reporting by Endpoints.

read at Endpoints ↗
113 words · retrieved 2h ago
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

no entities indexed yet

related stories

  • 59m agoAbbVie notches Phase 3 win in painful skin condition, FDA filing likely next yearEndpoints
  • 1h agoSanofi's new German site; radioisotope deals from Northstar and TelixEndpoints
  • 1h agoBig trials push beyond obesity to see if GLP-1s can quell alcohol, drug cravingsEndpoints
  • 2h agoHealthcare industry weighs in on evidence standards for generative AI medical devicesEndpoints
  • 3h agoGeorgiamune sells solid tumor drug to Italy's Menarini for up to $1.1BEndpoints